Literature DB >> 17131227

Weight loss in Parkinson's disease.

Kenichi Kashihara1.   

Abstract

Weight loss is frequent in patients with Parkinson's disease (PD). Reduced energy intake and/or increased energy expenditure have been postulated as the cause. Dysphagia, anorexia, and gastrointestinal dysfunction may be possible causes of reduced energy intake; whereas, rigidity, tremor, and levodopa-induced dyskinesia may increase energy expenditure. Levodopa may enhance glucose metabolism resulting in enhanced energy expenditure. Depression, anti-parkinsonian drugs, and medical complications such as pneumonia and malignancies also may facilitate weight loss in PD. Combinations of various degrees of these factors, especially in advanced PD, may produce weight loss. Such weight loss is associated with malnutrition which may precipitate infection and decubitis; accelerate motor, behavioral, and autonomic impairment; consequently spoiling one's quality of life. Attention must be paid as well to motor symptoms to prevent or reverse weight loss in PD patients.

Entities:  

Mesh:

Year:  2006        PMID: 17131227     DOI: 10.1007/s00415-006-7009-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  29 in total

1.  Weight gain following unilateral pallidotomy in Parkinson's disease.

Authors:  W G Ondo; L Ben-Aire; J Jankovic; E Lai; C Contant; R Grossman
Journal:  Acta Neurol Scand       Date:  2000-02       Impact factor: 3.209

2.  [Relationship between weight loss and dysphagia in patients with Parkinson's disease].

Authors:  S Nozaki; T Saito; T Matsumura; I Miyai; J Kang
Journal:  Rinsho Shinkeigaku       Date:  1999-10

3.  Raised resting energy expenditure in Parkinson's disease and its relationship to muscle rigidity.

Authors:  H S Markus; M Cox; A M Tomkins
Journal:  Clin Sci (Lond)       Date:  1992-08       Impact factor: 6.124

4.  [Increase of energy expenditure in Parkinson's disease].

Authors:  E Broussolle; F Borson; J M Gonzalez de Suso; J A Chayvialle; M Beylot; G Chazot
Journal:  Rev Neurol (Paris)       Date:  1991       Impact factor: 2.607

5.  Predictors of weight loss in Parkinson's disease.

Authors:  Ergun Y Uc; Lynn K Struck; Robert L Rodnitzky; Bridget Zimmerman; Judith Dobson; William J Evans
Journal:  Mov Disord       Date:  2006-07       Impact factor: 10.338

6.  Review of 12 months' treatment with L-dopa in Parkinson's disease, with remarks on unusual side effects.

Authors:  J Wodak; B S Gilligan; J L Veale; B J Dowty
Journal:  Med J Aust       Date:  1972-12-02       Impact factor: 7.738

7.  Serum leptin concentrations and satiety in Parkinson's disease patients with and without weight loss.

Authors:  V G Evidente; J N Caviness; C H Adler; K A Gwinn-Hardy; R E Pratley
Journal:  Mov Disord       Date:  2001-09       Impact factor: 10.338

Review 8.  Gastrointestinal dysfunction in Parkinson's disease.

Authors:  Ronald F Pfeiffer
Journal:  Lancet Neurol       Date:  2003-02       Impact factor: 44.182

Review 9.  The relationship between diabetes mellitus and Parkinson's disease.

Authors:  R Sandyk
Journal:  Int J Neurosci       Date:  1993 Mar-Apr       Impact factor: 2.292

10.  Weight change and body composition in patients with Parkinson's disease.

Authors:  P L Beyer; M Y Palarino; D Michalek; K Busenbark; W C Koller
Journal:  J Am Diet Assoc       Date:  1995-09
View more
  26 in total

1.  A review of the use of zonisamide in Parkinson's disease.

Authors:  Pedro Emilio Bermejo; Buenaventura Anciones
Journal:  Ther Adv Neurol Disord       Date:  2009-09       Impact factor: 6.570

2.  Body composition in Spinocerebellar ataxia type 3 and 10 patients: Comparative study with control group.

Authors:  Christiane de M B Almeida Leite; Maria Eliana M Schieferdecker; Caroline Frehner; Renato P Munhoz; Tetsuo Ashizawa; Hélio A G Teive
Journal:  Nutr Neurosci       Date:  2018-05-07       Impact factor: 4.994

Review 3.  PGC-1α at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond.

Authors:  Taiji Tsunemi; Albert R La Spada
Journal:  Prog Neurobiol       Date:  2011-11-09       Impact factor: 11.685

4.  The relationship between clinical phenotype and early staged bilateral deep brain stimulation in Parkinson disease.

Authors:  Victor W Sung; Ray L Watts; Christian J Schrandt; Stephanie Guthrie; Deli Wang; Amy W Amara; Barton L Guthrie; Harrison C Walker
Journal:  J Neurosurg       Date:  2013-09-27       Impact factor: 5.115

Review 5.  Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease.

Authors:  David A Gallagher; Anette Schrag
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

6.  Nutritional therapies in Parkinson's disease.

Authors:  Marian L Evatt
Journal:  Curr Treat Options Neurol       Date:  2007-05       Impact factor: 3.598

7.  Serum adiponectin levels in advanced-stage Parkinson's disease patients.

Authors:  Erica Cassani; Raffaella Cancello; Ferruccio Cavanna; Sabrina Maestrini; Anna Maria Di Blasio; Antonio Liuzzi; Gianni Pezzoli; Michela Barichella
Journal:  Parkinsons Dis       Date:  2011-06-16

8.  Body Mass Index Decline Is Related to Spinocerebellar Ataxia Disease Progression.

Authors:  Alhassane Diallo; Heike Jacobi; Tanja Schmitz-Hübsch; Arron Cook; Robyn Labrum; Alexandra Durr; Alexis Brice; Perrine Charles; Cecilia Marelli; Caterina Mariotti; Lorenzo Nanetti; Marta Panzeri; Maria Rakowicz; Anna Sobanska; Anna Sulek; Ludger Schöls; Holger Hengel; Bela Melegh; Alessandro Filla; Antonella Antenora; Jon Infante; José Berciano; Bart P van de Warrenburg; Dagmar Timmann; Sylvia Boesch; Massimo Pandolfo; Jörg B Schulz; Peter Bauer; Paola Giunti; Laszlo Baliko; Michael H Parkinson; Jun-Suk Kang; Thomas Klockgether; Sophie Tezenas du Montcel
Journal:  Mov Disord Clin Pract       Date:  2017-08-11

9.  Human disease-associated genetic variation impacts large intergenic non-coding RNA expression.

Authors:  Vinod Kumar; Harm-Jan Westra; Juha Karjalainen; Daria V Zhernakova; Tõnu Esko; Barbara Hrdlickova; Rodrigo Almeida; Alexandra Zhernakova; Eva Reinmaa; Urmo Võsa; Marten H Hofker; Rudolf S N Fehrmann; Jingyuan Fu; Sebo Withoff; Andres Metspalu; Lude Franke; Cisca Wijmenga
Journal:  PLoS Genet       Date:  2013-01-17       Impact factor: 5.917

Review 10.  Mechanisms of body weight fluctuations in Parkinson's disease.

Authors:  Andrea Kistner; Eugénie Lhommée; Paul Krack
Journal:  Front Neurol       Date:  2014-06-02       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.